A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z| A | | A novel binding site in voltage gated potassium channels revealed by the marine toxin gambierol | | Kopljar I., Labro A.J., Cuypers E., Rainier J., Tytgat J., Snyders D. | | | | Acceleration of hERG1 channel activation and deactivation by the amiodarone derivative KB130015 | | Macianskiene R., Gwanyanya A., Gessner G., Heinemann S.H., Mubagwa K., Starkus J.G. | | | | Altered striatal glutamate transporter functioning could explain aberrant glutamatergic neurotransmission in striatum of hemi-parkinson rat model | | Massie A., Goursaud S., Schallier A., Vermoesen K., Arckens L., Meshul C., Hermans E., Michotte Y. | | | | Analysis of renal phenotype of hyaluronidase-1 or hyaluronidase-2 knockout mice | | Colombaro V., Voisin V., Decleves A.E., Giordano L., Habsch I., Flamion B., Caron N. | | | | Anticonvulsant effects of ghrelin receptor ligands against pilocarpine-induced limbic seizures | | Portelli J., Aourz N., Ver Donck L., Michotte Y., Smolders I. | | | | Anticonvulsive effects of insulin-regulated aminopeptidase deletion in a pentylenetetrazol mouse seizure model are not mediated by the accumulation of somatostatin-14 | | Loyens E., Schallier A., De Bundel D., Demaegdt H., Chai S.Y., Albiston A.L., Vauquelin G., Vanderheyden P., Michotte Y., Smolders I. | | | | Apomorphine induced neuroprotection in an animal model of parkinsons disease | | Varcin M., Yuan H., Mertens B., Michotte Y., Sarre S. | | |
|